Nursing Tip of the Day! - Fundamentals

Category: Fundamentals 
A patient with hypoglycemia from sulfonylureas, in addition to standard glucose replacement, frequently requires treatment with an agent to inhibit further insulin release, such as octreotide, a somatostatin analogue.